Home Cart Sign in  
Chemical Structure| 1239875-86-5 Chemical Structure| 1239875-86-5

Structure of SGI-7079
CAS No.: 1239875-86-5

Chemical Structure| 1239875-86-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SGI-7079, a selective Axl inhibitor, inhibits tumor growth in a dose dependent manner and is a potential therapeutic target for overcoming EGFR inhibitor resistance.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SGI-7079

CAS No. :1239875-86-5
Formula : C26H26FN7
M.W : 455.53
SMILES Code : N#CCC1=CC=CC(C2=C3C(NC=C3C)=NC(NC4=CC=C(N5CCN(C)CC5)C(F)=C4)=N2)=C1
MDL No. :MFCD28963942
InChI Key :BCFKACXAIBEPKR-UHFFFAOYSA-N
Pubchem ID :46870258

Safety of SGI-7079

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of SGI-7079

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
KPL-4 cells 0.16 µM 72 hours Inhibited the proliferation of KPL-4 cells with an IC50 of 0.16 µM. PMC6135947
SUM149 cells 0.43 µM 72 hours Inhibited the proliferation of SUM149 cells with an IC50 of 0.43 µM. PMC6135947
H460 cells 0.1 µM 48 hours Co-inhibition of AXL and SRC effectively blocked KRAS activity and promoted cell death PMC11816174
A549 cells 0.1 µM 48 hours Co-inhibition of AXL and SRC effectively blocked KRAS activity and promoted cell death PMC11816174

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice A549 xenograft model Oral 25 mg/kg 5 days a week, continuous treatment Dual inhibition of AXL and SRC significantly suppressed tumor growth PMC11816174
Mice A549 xenograft model Not specified 25/100 mg/kg Not specified To test the inhibitory effect of SGI-7079 alone or in combination with erlotinib on tumor growth PMC3567921

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.20mL

0.44mL

0.22mL

10.98mL

2.20mL

1.10mL

21.95mL

4.39mL

2.20mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories